Wesche Holger 4
4 · Harpoon Therapeutics, Inc. · Filed Nov 15, 2021
Insider Transaction Report
Form 4
Wesche Holger
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-11-11+135,000→ 135,000 totalExercise: $7.73Exp: 2031-11-11→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]Fifty percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 11, 2022, and thereafter twenty-five percent of the stock option shall vest on each May 11, 2023, and November 11, 2023.